|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Restricted cash | ||||||||||||||||||
| Accounts receivable, net of allowance for credit losses | ||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||
| Current assets held for sale | ||||||||||||||||||
| Total Current Assets | ||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||
| Finance leases, net | ||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||
| Deposits and other assets | ||||||||||||||||||
| Deposits | ||||||||||||||||||
| Other assets | ||||||||||||||||||
| Total Assets | ||||||||||||||||||
| Current liabilities | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||
| Deferred revenue | ||||||||||||||||||
| Customer deposits | ||||||||||||||||||
| Current portion of note payable | ||||||||||||||||||
| Current portion of long-term operating leases | ||||||||||||||||||
| Current portion of finance leases | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Other liabilities | ||||||||||||||||||
| Note payable, net of unamortized debt issuance costs | ||||||||||||||||||
| Long-term operating leases | ||||||||||||||||||
| Long-term finance leases | ||||||||||||||||||
| Other liabilities | ||||||||||||||||||
| Total other liabilities | ||||||||||||||||||
| Total Liabilities | ||||||||||||||||||
| Stockholders' Equity (Deficit) | ||||||||||||||||||
| $.001 par value; 144,462,687, 5,537,313 and 50,000,000 authorized; 52,546,045, 5,537,313, 9,089,107 and 50,992,033, 5,537,313, 9,089,107 issued and outstanding as of June 30 2026 and December 31, 2025, for Common Stock, Class A Non-voting Common Stock, and Class B Non-voting Common Stock, respectively | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Retained deficit | ||||||||||||||||||
| Total Company's stockholders' deficit | ||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||
| Total Liabilities and Deficit | ||||||||||||||||||
Loading...
